ArticleAddictive behaviors reports2026
The mediating role of anxiety and depression symptoms in the relationship between ADHD symptoms and polysubstance use among French university students: the i-share study.
Article in Addictive behaviors reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polysubstance use, depressive disorder, and anxiety disorder are frequent comorbidities in adults with ADHD. This study aimed to explore the mediation role of anxiety and depression symptoms in the association between ADHD symptoms and polysubstance use. Methods: The study included 1675 French university students from February 2013 to July 2020 as part of the i-Share cohort. Time 1: ADHD symptoms were assessed using the Adult ADHD Self-Report Scale. Time 2: Anxiety and depression symptoms were evaluated using the State-Trait Anxiety Inventory-Y trait and the Patient Health Questionnaire-9, respectively. Time 3: Substance use was assessed through a self-reported questionnaire. We conducted a mediation analysis using structural equation modeling. Results: The study included 1675 participants. At time 1, the level of ADHD symptoms was moderate (m: 10.66, sd: 3.99). At time 2, both anxiety (m: 47.11, sd: 10.57) and depression (m: 6.92, sd: 5.33) symptoms were moderate. At time 3, 93.49% (1566) of participants had used substances. The direct effect between ADHD factor and polysubstance use factor was of 1.66 (1.04-2.48). The indirect effects between ADHD factor and polysubstance use factor were through anxiety factor -0.68 (-1.15 to -0.37) and through depression factor -0.57 (-0.94 to -0.32). Although the mediation effects through anxiety and depression factors were negative, the total effect remained positive and significant (0.41 (0.27 to 0.59)). Discussion: Anxiety factor and depression factor acted as negative and partial mediators in the association between ADHD factor and polysubstance use factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.